David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 14,866 shares at $33.27 ($483K) on 2026-01-09, disclosed to the SEC on 2026-01-13.
Open-market sale of $483k MLYS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.27 | 2,170 | $72K | 15.0% |
| 2 | $32.32 | 6,348 | $205K | 42.5% |
| 3 | $32.32 | 6,348 | $205K | 42.5% |
| Total | $32.46 avg | 14,866 | $483K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |